{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:07:11Z","timestamp":1777547231311,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.puhe.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:46:26Z","timestamp":1708490786000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation"],"prefix":"10.1016","volume":"228","author":[{"given":"Kailu","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5491-8066","authenticated-orcid":false,"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2024.01.012_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2024.01.012_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2468-1253(22)00009-7","article-title":"Global elimination of hepatitis C: a warning from the data","volume":"7","author":"Dusheiko","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2024.01.012_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2024.01.012_bib4","series-title":"Health sector strategies on HIV, viral hepatitis and sexually transmitted infections 2022-2030","year":"2021"},{"key":"10.1016\/j.puhe.2024.01.012_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MCG.0000000000000109","article-title":"Current challenges and the management of chronic hepatitis C in mainland China","volume":"48","author":"Duan","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.puhe.2024.01.012_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-015-1322-0","article-title":"Sustained high prevalence of viral hepatitis and sexually transmissible infections among female sex workers in China: a systematic review and meta-analysis","volume":"16","author":"Su","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.puhe.2024.01.012_bib7","first-page":"888","article-title":"A\u00a0sero-epidemiological study on hepatitis C in China","volume":"32","author":"Chen","year":"2011","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1016\/j.puhe.2024.01.012_bib8","series-title":"The research report on the current situation of hepatitis C infection in China and its prevention and treatment strategies","author":"Zhuang","year":"2017"},{"key":"10.1016\/j.puhe.2024.01.012_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciu245","article-title":"The HIV, syphilis, and HCV epidemics among female sex workers in China: results from a serial cross-sectional study between 2008 and 2012","volume":"59","author":"Wang","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2024.01.012_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2024.01.012_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2018.05.027","article-title":"Assessing the cost-effectiveness of hepatitis C screening strategies in France","volume":"69","author":"Deuffic-Burban","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.puhe.2024.01.012_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/14787210.2019.1675509","article-title":"How would China achieve WHO's target of eliminating HCV by 2030?","volume":"17","author":"Li","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.puhe.2024.01.012_bib13","unstructured":"Macrotrends. China life expetancy 1950-2022. https:\/\/www.macrotrends.net\/countries\/CHN\/china\/life-expectancy (Assessed May 23, 2022)."},{"key":"10.1016\/j.puhe.2024.01.012_bib14","series-title":"China population census yearbook 2020","year":"2021"},{"key":"10.1016\/j.puhe.2024.01.012_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.puhe.2024.01.012_bib16","first-page":"247","article-title":"Current status of diagnosis and treatment of hepatitis C in medical institutions","volume":"26","author":"Feng","year":"2020","journal-title":"Chin J AIDS STD"},{"key":"10.1016\/j.puhe.2024.01.012_bib17","article-title":"Will sofosbuvir\/ledipasvir (Harvoni) Be cost-effective and affordable for Chinese patients infected with hepatitis C virus? An economic analysis using real-world data","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.puhe.2024.01.012_bib18","series-title":"Economic analysis for liver and renal transplant in a transplant center [A master's degree]","author":"Gao","year":"2007"},{"key":"10.1016\/j.puhe.2024.01.012_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.puhe.2024.01.012_bib20","first-page":"673","article-title":"Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE","volume":"10","author":"Bertram","year":"2021","journal-title":"Int J Health Policy Manag"},{"key":"10.1016\/j.puhe.2024.01.012_bib21","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/S2214-109X(21)00517-9","article-title":"Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation","volume":"10","author":"Su","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.puhe.2024.01.012_bib22","series-title":"National Bureau of Statistics of China. China population and employment statistics yearbook","year":"2021"},{"key":"10.1016\/j.puhe.2024.01.012_bib23","series-title":"WHO guide to cost-effectiveness analysis","year":"2003"},{"key":"10.1016\/j.puhe.2024.01.012_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cgh.2018.12.002","article-title":"Universal screening for hepatitis C: an important step in virus elimination","volume":"17","author":"Chhatwal","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2024.01.012_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciw075","article-title":"Can hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the HCV epidemic among men who have sex with men in the United Kingdom? Epidemiological and modeling insights","volume":"62","author":"Martin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2024.01.012_bib26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2020-321744","article-title":"Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach","volume":"70","author":"Castry","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.puhe.2024.01.012_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00508-021-01898-9","article-title":"Outcomes of an HCV elimination program targeting the Viennese MSM population","volume":"133","author":"Jachs","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.puhe.2024.01.012_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.drugpo.2019.10.012","article-title":"Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia","volume":"74","author":"Saludes","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.puhe.2024.01.012_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.puhe.2024.01.012_bib30","series-title":"2015 China AIDS response progress report","year":"2015"},{"key":"10.1016\/j.puhe.2024.01.012_bib31","series-title":"Country factsheets: China 2016 [internet]","year":"2016"},{"key":"10.1016\/j.puhe.2024.01.012_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.puhe.2024.01.012_bib33","first-page":"262","article-title":"Knowledge of hepatitis C prevention and treatment among drug users. Reliability and validity of a questionnaire on knowledge of hepatitis C prevention and treatment among drug addicts","volume":"37","author":"Pan","year":"2020","journal-title":"China Health Stat"},{"key":"10.1016\/j.puhe.2024.01.012_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fpubh.2019.00327","article-title":"The decade-long Chinese methadone maintenance therapy yields large population and economic benefits for drug users in reducing harm, HIV and HCV disease burden","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Public Health"},{"issue":"Suppl 2","key":"10.1016\/j.puhe.2024.01.012_bib35","first-page":"ii14","article-title":"Contributions of international cooperation projects to the HIV\/AIDS response in China","volume":"39","author":"Sun","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.puhe.2024.01.012_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.15288\/jsad.2018.79.248","article-title":"Decreasing HIV, syphilis, and hepatitis C infection after a decade of harm reduction implementation among drug users in southwestern areas of China","volume":"79","author":"Chen","year":"2018","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.puhe.2024.01.012_bib37","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2024.01.012_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vhri.2018.01.009","article-title":"Recent pricing negotiations on innovative medicines pilot in China: experiences, implications, and suggestions","volume":"15","author":"Li","year":"2018","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.puhe.2024.01.012_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40249-023-01081-4","article-title":"Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021","volume":"12","author":"Du","year":"2023","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.puhe.2024.01.012_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008162","article-title":"Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study","volume":"5","author":"Zou","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.puhe.2024.01.012_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.puhe.2024.01.012_bib42","first-page":"1427","article-title":"Eliminate hepatitis C as a public health threat: a narrative review of strategies, gaps, and opportunities for China","volume":"11","author":"Song","year":"2022","journal-title":"Infect Dis Ther"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350624000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350624000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:45:04Z","timestamp":1758501904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350624000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S0033350624000325"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2024.01.012","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}]}}